SCHEMBL3844913

SCHEMBL3844913

O=C(O)c1ccc(-c2ncnc3ccc(Cl)cc23)cc1F

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 4/20 0.50
DHODH Q02127 5/20 0.49
CAMKK1 Q8N5S9 6/20 0.48
CAMKK2 Q96RR4 6/20 0.48
PTGES O14684 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ALOX5 P09917 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CASP7 P55210 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
KMO O15229 1/20 0.42
RAF1 P04049 1/20 0.41
BRAF P15056 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847833 0.91 DHODH (0.50) PDK1DHODHCAMKK1CAMKK2PTGES
SCHEMBL3846537 0.83 CAMKK1 (0.48) PDK1CAMKK1CAMKK2PDK2PDK3
SCHEMBL3846054 0.82 PDK1 (0.46) PDK1CAMKK1CAMKK2ALDH1A1HPGD
SCHEMBL14145475 0.79 MAP4K4 (0.50) PDK1PDK2PDK3PDK4KMO
SCHEMBL3846925 0.77 JAK3 (0.48) PDK1CAMKK1CAMKK2ALDH1A1PDK2
SCHEMBL10718258 0.73 ADORA2A (0.62) PDK1ALDH1A1HPGDCASP7HIF1A
SCHEMBL3847105 0.73 CAMKK2 (0.47) PDK1CAMKK1CAMKK2
SCHEMBL6017915 0.73 RARB (0.55) DHODHALDH1A1HSD17B10
SCHEMBL392840 0.72 SMN1; SMN2 (0.63) ALDH1A1HSD17B10KMOMRGPRX4
SCHEMBL4191067 0.72 DHODH (0.47) DHODHKMOMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed